ARPICCO, Silvia Maria Angela
ARPICCO, Silvia Maria Angela
SCIENZA E TECNOLOGIA DEL FARMACO
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
1998-01-01 M. CERUTI; F. ROCCO; F. VIOLA; G. BALLIANO; P. MILLA; S. ARPICCO; L. CATTEL
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al.
2014-01-01 Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions
2001-01-01 CATTEL L; RECALENDA V; AIROLDI M; TAGINI V; ARPICCO S; BRUSA P; BUMMA C
Advances in anticancer antibody-drug conjugates and immunotoxins.
2014-01-01 F. Dosio; B. Stella; S. Cerioni; D. Gastaldi; S. Arpicco
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle
2023-01-01 Calderan, Laura; Carton, Flavia; Andreana, Ilaria; Bincoletto, Valeria; Arpicco, Silvia; Stella, Barbara; Malatesta, Manuela
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
2024-01-01 Francesca Susa; Silvia Arpicco; Candido Fabrizio Pirri; Tania Limongi
Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus “Expanded Haemodialysis”
2024-01-01 Ferrari, Fiorenza; Milla, Paola; Sartori, Marco; Zanza, Christian; Tesauro, Manfredi; Longhitano, Yaroslava; De Silvestri, Annalisa; Abbruzzese, Chiara; De Rosa, Silvia; Lassola, Sergio; Samoni, Sara; Brendolan, Alessandra; Zanella, Monica; Scaravilli, Vittorio; Grasselli, Giacomo; Arpicco, Silvia; Ronco, Claudio
Anticancer prodrugs: an overview of major strategies and recent developments.
2011-01-01 ARPICCO S; DOSIO F; STELLA B; CATTEL L
ANTITUMORAL ACTIVITY OF LIPOSOMES AND IMMUNOLIPOSOMES CONTAINING 5-FLUOROURIDINE PRODRUGS
1997-01-01 P. CROSASSO; P. BRUSA; F. DOSIO; S. ARPICCO; D. PACCHIONI; F. SCHUBER; L. CATTEL
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid
2008-01-01 PASUT G; CANAL F; VIA LD; ARPICCO S; VERONESE FA; SCHIAVON O
Biological characterisation of folic acid-conjugated nanoparticles in cellular models
2001-01-01 B. Stella; V. Marsaud; S. Arpicco; M.T. Peracchia; G. Géraud; M.L. Immordino; L. Cattel; P. Couvreur; M. Renoir
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models
2007-01-01 STELLA B; MARSAUD V; ARPICCO S; GERAUD G; CATTEL L; COUVREUR P; RENOIR JM
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
2021-01-01 Stella B.; Baratta F.; Della Pepa C.; Arpicco S.; Gastaldi D.; Dosio F.
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico
2000-01-01 B. Stella; S. Arpicco; M.T. Peracchia; D. Desmaële; J. Hoebeke; M.L. Immordino; J. d’Angelo; P. Couvreur; L. Cattel
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici.
2000-01-01 Cattel L.; Arpicco S.; Ceruti M.; Rocco F.; Dosio F.; Brusa P.
Cationic liposomes contaiing a DOPE-hyaluronate conjugate for gene delivery
2008-01-01 S. Arpicco; C. Surace; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery
2007-01-01 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery
2008-01-01 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery
2007-01-01 C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal
Cationic liposomes containing a DOPE-hyaluronate conjugate for gene delivery.
2010-01-01 S. Arpicco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. | 1998 | M. CERUTI; F. ROCCO; F. VIOLA; G. BALLIANO; P. MILLA; S. ARPICCO; L. CATTEL | |
| A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. | 2014 | Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero | |
| A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions | 2001 | CATTEL L; RECALENDA V; AIROLDI M; TAGINI V; ARPICCO S; BRUSA P; BUMMA C | |
| Advances in anticancer antibody-drug conjugates and immunotoxins. | 2014 | F. Dosio; B. Stella; S. Cerioni; D. Gastaldi; S. Arpicco | |
| An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle | 2023 | Calderan, Laura; Carton, Flavia; Andreana, Ilaria; Bincoletto, Valeria; Arpicco, Silvia; Stella, Barbara; Malatesta, Manuela | |
| An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery | 2024 | Francesca Susa; Silvia Arpicco; Candido Fabrizio Pirri; Tania Limongi | |
| Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus “Expanded Haemodialysis” | 2024 | Ferrari, Fiorenza; Milla, Paola; Sartori, Marco; Zanza, Christian; Tesauro, Manfredi; Longhitano, Yaroslava; De Silvestri, Annalisa; Abbruzzese, Chiara; De Rosa, Silvia; Lassola, Sergio; Samoni, Sara; Brendolan, Alessandra; Zanella, Monica; Scaravilli, Vittorio; Grasselli, Giacomo; Arpicco, Silvia; Ronco, Claudio | |
| Anticancer prodrugs: an overview of major strategies and recent developments. | 2011 | ARPICCO S; DOSIO F; STELLA B; CATTEL L | |
| ANTITUMORAL ACTIVITY OF LIPOSOMES AND IMMUNOLIPOSOMES CONTAINING 5-FLUOROURIDINE PRODRUGS | 1997 | P. CROSASSO; P. BRUSA; F. DOSIO; S. ARPICCO; D. PACCHIONI; F. SCHUBER; L. CATTEL | |
| Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid | 2008 | PASUT G; CANAL F; VIA LD; ARPICCO S; VERONESE FA; SCHIAVON O | |
| Biological characterisation of folic acid-conjugated nanoparticles in cellular models | 2001 | B. Stella; V. Marsaud; S. Arpicco; M.T. Peracchia; G. Géraud; M.L. Immordino; L. Cattel; P. Couvreur; M. Renoir | |
| Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models | 2007 | STELLA B; MARSAUD V; ARPICCO S; GERAUD G; CATTEL L; COUVREUR P; RENOIR JM | |
| Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain | 2021 | Stella B.; Baratta F.; Della Pepa C.; Arpicco S.; Gastaldi D.; Dosio F. | |
| Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico | 2000 | B. Stella; S. Arpicco; M.T. Peracchia; D. Desmaële; J. Hoebeke; M.L. Immordino; J. d’Angelo; P. Couvreur; L. Cattel | |
| Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. | 2000 | Cattel L.; Arpicco S.; Ceruti M.; Rocco F.; Dosio F.; Brusa P. | |
| Cationic liposomes contaiing a DOPE-hyaluronate conjugate for gene delivery | 2008 | S. Arpicco; C. Surace; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal | |
| Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery | 2007 | C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal | |
| Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery | 2008 | C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal | |
| Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery | 2007 | C. Surace; S. Arpicco; V. Marsaud; C. Bouclier; M. Renoir; L. Cattel; E. Fattal | |
| Cationic liposomes containing a DOPE-hyaluronate conjugate for gene delivery. | 2010 | S. Arpicco |